Japan Animal Referral Medical Center Co., Ltd. (6039) AI Stock Analysis

• Market Cap: ¥7.01B
• Dividend Yield: 1.49%
• Average Volume (3M): 7.16K
• Price to Earnings (P/E): 12.3
• Beta (1Y): 0.38
• Revenue Growth: 25.13%
• EPS Growth: 71.81%
• Country: JP
• Employees: 256
• Sector: Consumer Cyclical
• Sector Strength: 74
• Industry: Personal Products & Services
• EPS (TTM): 43.26
• Shares Outstanding: 2,878,200
• 10 Day Avg. Volume: 15,560
• 30 Day Avg. Volume: 7,163
• PEG Ratio: 1.15
• Price to Book (P/B): 1.65
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 71 Outperform
• Price Target: ―

Japan Animal Referral Medical Center Co., Ltd. exhibits strong financial performance with notable revenue and profit growth. While the balance sheet remains stable, the company's debt levels and cash flow volatility pose risks. The stock's technical indicators suggest a mixed outlook, with a potential downward short-term trend. Valuation metrics indicate the stock is reasonably priced, with a modest dividend yield enhancing its investment appeal.

Japan Animal Referral Medical Center Co., Ltd. Business Overview & Revenue Model

Company Description

Japan Animal Referral Medical Center Co., Ltd. (6039) is a leading veterinary services provider in Japan, specializing in advanced animal medical care. The company operates state-of-the-art referral medical centers that offer a wide range of specialized services for pets, including surgery, oncology, cardiology, and diagnostic imaging. As a trusted name in the veterinary industry, it collaborates with general veterinary practitioners to provide comprehensive care for complex medical cases.

How the Company Makes Money

Japan Animal Referral Medical Center Co., Ltd. generates revenue primarily through the provision of specialized veterinary medical services. The company operates referral centers where pet owners, often directed by their primary veterinarians, seek advanced medical treatments for their animals. Revenue streams include fees for diagnostics, surgical procedures, and specialized treatments such as oncology and cardiology services. The company also benefits from partnerships with veterinary specialists and equipment suppliers, enhancing its service offerings and operational efficiency. Additionally, the center may engage in educational activities and professional training for veterinary practitioners, which could provide supplementary income.

Japan Animal Referral Medical Center Co., Ltd. Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
TTM	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
5.10B	4.27B	3.87B	2.98B	2.85B	2.73B
	Gross Profit
1.82B	1.46B	1.44B	1.11B	994.66M	991.85M
	EBIT
741.54M	496.92M	580.55M	439.24M	405.54M	430.69M
	EBITDA
1.12B	977.87M	967.61M	681.00M	649.81M	695.32M
	Net Income Common Stockholders
525.81M	337.22M	380.66M	286.94M	285.19M	312.82M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
1.03B	1.34B	1.92B	1.07B	1.21B	1.25B
	Total Assets
8.63B	8.77B	8.58B	7.11B	5.84B	5.93B
	Total Debt
3.64B	3.86B	3.98B	3.92B	3.07B	3.40B
	Net Debt
2.62B	2.52B	2.06B	2.85B	1.86B	2.25B
	Total Liabilities
4.59B	4.96B	4.87B	4.60B	3.51B	3.79B
	Stockholders Equity
4.04B	3.81B	3.71B	2.51B	2.34B	2.13B
Cash Flow		Free Cash Flow
0.00	-155.41M	68.98M	-44.36M	438.89M	450.10M
	Operating Cash Flow
0.00	899.78M	810.92M	557.57M	504.39M	537.98M
	Investing Cash Flow
0.00	-985.86M	-784.07M	-1.43B	-69.57M	-93.45M
	Financing Cash Flow
0.00	-392.32M	820.59M	722.09M	-469.43M	-445.59M

Japan Animal Referral Medical Center Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2480.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6039, the sentiment is Negative. The current price of 2480 is below the 20-day moving average (MA) of 2611.75, below the 50-day MA of 2570.01, and above the 200-day MA of 2234.56, indicating a neutral trend. The MACD of -17.97 indicates Positive momentum. The RSI at 42.60 is Neutral, neither overbought nor oversold. The STOCH value of 38.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6039.

Japan Animal Referral Medical Center Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2371	76 Outperform	$498.53B	25.05	34.91%	1.89%	15.40%	30.51%
2374	74 Outperform	¥18.20B	12.07		4.12%	4.02%	-27.53%
6039	71 Outperform	¥7.01B	12.33		1.49%	25.13%	71.81%
Sector *	62 Neutral	$6.97B	11.36	2.77%	3.91%	2.66%	-22.00%
2372	60 Neutral	$33.78B	41.81		1.44%	8.41%	-36.67%
2373	58 Neutral	¥5.37B	12.27		4.26%	10.13%	―
2375	50 Neutral	¥4.92B	―		0.42%	-5.06%	-52.77%

Japan Animal Referral Medical Center Co., Ltd. Corporate Events

JARMeC Reports Significant Financial Growth in 2024

JARMeC reported significant financial growth for the nine months ending December 31, 2024, with net sales increasing by 26.5% and operating profit rising by 70.8% compared to the previous year. The company’s strong performance underscores its solid market position and potential positive impacts for stakeholders.